(Q58690844)

English

The Florida Melanoma Trial I: A Prospective Multicenter Phase I/II Trial of Postoperative Hypofractionated Adjuvant Radiotherapy with Concurrent Interferon-Alfa-2b in the Treatment of Advanced Stage III Melanoma with Long-Term Toxicity Follow-Up

article

In more languages

Statements

scholarly article

0 references

The Florida Melanoma Trial I: A Prospective Multicenter Phase I/II Trial of Postoperative Hypofractionated Adjuvant Radiotherapy with Concurrent Interferon-Alfa-2b in the Treatment of Advanced Stage III Melanoma with Long-Term Toxicity Follow-Up (English)

0 references

multicenter clinical trial

1 reference

based on heuristic

inferred from title

phase I clinical trial

1 reference

based on heuristic

inferred from title

Vernon K Sondak

7

object named as

Vernon Sondak

0 references

6

object named as

Lynn Feun

0 references

author name string

Steven E. Finkelstein

1

0 references

Andy Trotti

2

0 references

Nikhil Rao

3

0 references

Douglas Reintgen

4

0 references

Wayne Cruse

5

0 references

Daohai Yu

8

0 references

Weiwei Zhu

9

0 references

Clement Gwede

10

0 references

Ronald DeConti

11

0 references

publication date

2012

0 references

ISRN Immunology

0 references

2012

0 references

1-10

0 references

copyright license

Creative Commons Attribution 3.0 Unported

19 February 2012

1 reference

April 2022 Public Data File from Crossref

copyright status

1 reference

April 2022 Public Data File from Crossref

Cancer statistics, 2010

1 reference

https://api.crossref.org/works/10.5402%2F2012%2F324235

21 January 2018

Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684.

1 reference

https://api.crossref.org/works/10.5402%2F2012%2F324235

21 January 2018

High- and low-dose interferon alfa-2b in high-risk melanoma: first analysis of intergroup trial E1690/S9111/C9190.

1 reference

https://api.crossref.org/works/10.5402%2F2012%2F324235

21 January 2018

Regional radiotherapy as adjuvant treatment for head and neck malignant melanoma. Preliminary results

1 reference

https://api.crossref.org/works/10.5402%2F2012%2F324235

21 January 2018

A pooled analysis of eastern cooperative oncology group and intergroup trials of adjuvant high-dose interferon for melanoma

1 reference

https://api.crossref.org/works/10.5402%2F2012%2F324235

21 January 2018

Immunotherapy: Vaccine trials in melanoma -- time for reflection

1 reference

https://api.crossref.org/works/10.5402%2F2012%2F324235

21 January 2018

Does Adjuvant Vaccine Therapy Really Have Activity in Malignant Melanoma?

1 reference

https://api.crossref.org/works/10.5402%2F2012%2F324235

21 January 2018

Combined adjuvant radiation and interferon-alpha 2B therapy in high-risk melanoma patients: the potential for increased radiation toxicity.

1 reference

https://api.crossref.org/works/10.5402%2F2012%2F324235

21 January 2018

Concurrent adjuvant radiotherapy and interferon-alpha2b for resected high risk stage III melanoma -- a retrospective single centre study

1 reference

https://api.crossref.org/works/10.5402%2F2012%2F324235

21 January 2018

Adjuvant radiation therapy for high-risk nodal metastases from cutaneous melanoma

1 reference

https://api.crossref.org/works/10.5402%2F2012%2F324235

21 January 2018

Bedside to bench and back again: how animal models are guiding the development of new immunotherapies for cancer

1 reference

https://api.crossref.org/works/10.5402%2F2012%2F324235

21 January 2018

Combination of external beam radiotherapy (EBRT) with intratumoral injection of dendritic cells as neo-adjuvant treatment of high-risk soft tissue sarcoma patients

1 reference

https://api.crossref.org/works/10.5402%2F2012%2F324235

21 January 2018

Serial assessment of lymphocytes and apoptosis in the prostate during coordinated intraprostatic dendritic cell injection and radiotherapy

1 reference

https://api.crossref.org/works/10.5402%2F2012%2F324235

21 January 2018

The confluence of stereotactic ablative radiotherapy and tumor immunology

1 reference

https://api.crossref.org/works/10.5402%2F2012%2F324235

21 January 2018

Identifiers

10.5402/2012/324235

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q58690844&oldid=1801166502"